Evidence map›Paper›PMID 37509100›Full record

ArticleBiomolecules2023

Activation of Metabotropic Glutamate Receptor (mGlu

Joanna M Wierońska, Paulina Cieślik, Grzegorz Burnat, Leszek Kalinowski

Open access · goldAbstract read
In one paragraph

Article in Biomolecules, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Joanna M WierońskaMaj Institute of Pharmacology Polish Academy of Sciences, Smętna 12, 31-343 Kraków, Poland.ORCID 0000-0002-2052-0973
Paulina CieślikMaj Institute of Pharmacology Polish Academy of Sciences, Smętna 12, 31-343 Kraków, Poland.
Grzegorz BurnatMaj Institute of Pharmacology Polish Academy of Sciences, Smętna 12, 31-343 Kraków, Poland.ORCID 0000-0002-2300-0850
Leszek KalinowskiDepartment of Medical Laboratory Diagnostics-Fahrenheit Biobank BBMRI.pl, Medical University of Gdansk, 7 Debinki Street, 80-211 Gdansk, Poland.ORCID 0000-0001-7270-1592
Maj Institute of Pharmacology · PLGdańsk University of Technology · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Morris water maze (MWM) is regarded as one of the most popular tests for detecting spatial memory in rodents. Long-term potentiation and cGMP synthesis seem to be among the crucial factors involved in this type of learning. Muscarinic (M

Indexed as

Dizocilpine MaleateReceptors, Metabotropic GlutamateAnimalsBenzamidesGlutamic AcidMorris Water Maze TestN-MethylaspartatePyridinesReceptors, MuscarinicSulfonamidesThiophenes3-amino-N-(4-methoxybenzyl)-4,6-dimethylthieno(2,3-b)pyridine-2-carboxamideBenzamidesDizocilpine MaleateGlutamic AcidN-(4-(2-methoxyphenoxy)phenyl)-N-(2,2,2-trifluoroethylsulfonyl)pyrid-3-ylmethylamineN-MethylaspartatePyridinesReceptors, Metabotropic GlutamateReceptors, MuscarinicSulfonamidesThiophenesVU0357017cGMPmGlu receptorsMorris water mazemuscarinic receptorsNMDAschizophreniaspatial learning

Identifiers

PMID37509100
PMCPMC10377483
OpenAlexW4382752971

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.